Destiny Pharma plc announced, ahead of the AGM, that Neil Clark has decided to step down as Chief Executive Officer to pursue new challenges. Neil will also step down from the board with immediate effect.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.75 GBX | 0.00% | 0.00% | -77.50% |
04-25 | Norcros sells Johnson Tiles UK; Trifast trading well | AN |
04-25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.50% | 19.14M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- DEST Stock
- News Destiny Pharma plc
- Destiny Pharma plc Announces the Step Down of Neil Clark from Board